167 related articles for article (PubMed ID: 22654452)
1. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma.
Wang XL; Cai HP; Ge JH; Su XF
World J Gastroenterol; 2012 May; 18(20):2540-4. PubMed ID: 22654452
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.
Jiang XM; Yu XN; Huang RZ; Zhu HR; Chen XP; Xiong J; Chen ZY; Huang XX; Shen XZ; Zhu JM
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2309-17. PubMed ID: 27601163
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
6. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
7. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
8. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
Hsu HS; Chen HW; Kao CL; Wu ML; Li AF; Cheng TH
Ann Surg Oncol; 2011 May; 18(5):1469-77. PubMed ID: 21080085
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.
Han B; Zhang Q; Li G; Zhang R; Li H
Med Sci Monit; 2019 Oct; 25():7936-7941. PubMed ID: 31641096
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation.
Tan J; Ye J; Song M; Zhou M; Hu Y
J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29112301
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
13. The HOX gene network in hepatocellular carcinoma.
Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo.
Fang D; Peng J; Wang G; Zhou D; Geng X
Int J Mol Med; 2019 Oct; 44(4):1325-1332. PubMed ID: 31432159
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
[TBL] [Abstract][Full Text] [Related]
16. [Expression and its clinical significance of eIF4E in non-small cell lung cancer].
ZHANG B; ZHU C; CHEN B; ZHANG X; YE M; LIN A
Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1132-5. PubMed ID: 21159249
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical value of eukaryotic initiation factor 4E and matrix metalloproteinase-9 in supraglottic and hypopharyngeal carcinoma and metastasis lymph].
Sun S; Liu Q; Zhang A; He E
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1116-9. PubMed ID: 17357517
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of the expression of eukaryotic initiation factor 4 E and mammalian target of rapamycin in esophageal squamous carcinoma tissues].
Lu J; Pan Y; Lei Y; Gu Y; Zhong F
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):905-8. PubMed ID: 26404688
[TBL] [Abstract][Full Text] [Related]
19. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
20. miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5‑fluorouracil by targeting EIF4E.
Yang X; Zang J; Pan X; Yin J; Xiang Q; Yu J; Gan R; Lei X
Oncol Rep; 2017 Jan; 37(1):563-570. PubMed ID: 27840964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
